Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy DOI Creative Commons
Ziliang Chen, Kaipeng Jia, Yi Zheng

et al.

Annals of Noninvasive Electrocardiology, Journal Year: 2024, Volume and Issue: 29(1)

Published: Jan. 1, 2024

Abstract Objective Patients treated with preoperative chemotherapy and immunotherapy for bladder cancer may be at increased risk of cardiotoxicity electrophysiological abnormalities. This study aimed to analyze their electrocardiographic (ECG) alterations. Methods who were hospitalized receiving tislelizumab plus nab‐paclitaxel (TnP) enrolled prospectively. ECG, cardiac biomarkers, echocardiography performed baseline the end TnP. Results A total 60 patients (76.7% males), including 30 muscle‐invasive non‐muscle‐invasive cancer, received three or four cycles TnP, respectively. Hypertension was commonest comorbidity (41.7%), 25 (41.7%) prescribed cardiovascular drugs. In comparison characteristics, troponin I (cTnI) N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) within normal ranges after However, echocardiographic parameter left ventricular ejection fraction slightly decreased TnP (62.81 ± 3.81% 61.10 4.37%, p = .011). The incidence abnormal ECG from 65.0% 76.7%, which only a higher prevalence fragmented QRS (fQRS) observed (33.3% 50.0%, .013; mainly in inferior leads). parameters QT dispersion (QTd) prolonged significantly regimen (39.50 11.37 44.20 15.85 ms, .019). Conclusion combined immunotherapy, main abnormality fQRS QTd, relatively biomarkers parameters. Regular screening should carried out carefully detect potential long‐term follow‐up.

Language: Английский

From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk DOI
Rafael Romero-Becerra, Ayelén M. Santamans, Alba C. Arcones

et al.

Physiology, Journal Year: 2023, Volume and Issue: 39(2), P. 98 - 125

Published: Dec. 5, 2023

The heart, once considered a mere blood pump, is now recognized as multifunctional metabolic and endocrine organ. Its function tightly regulated by various processes, at the same time it serves an organ, secreting bioactive molecules that impact systemic metabolism. In recent years, research has shed light on intricate interplay between heart other organs, such adipose tissue, liver, skeletal muscle. flexibility of its ability to switch different energy substrates play crucial role in maintaining cardiac overall homeostasis. Gaining comprehensive understanding how disorders disrupt metabolism crucial, plays pivotal development progression diseases. emerging organ highlights essential contribution whole body regulation offers new insights into pathogenesis diseases, obesity, diabetes, cardiovascular disorders. this review, we provide in-depth exploration heart's functions, emphasizing organs. Furthermore, evidence suggests correlation disease conditions aging cancer, indicating dysfunction observed these may share common underlying mechanisms. By unraveling complex mechanisms metabolism, aim contribute novel therapeutic strategies for diseases improve health.

Language: Английский

Citations

6

HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton DOI Open Access
Romina Cabrera-Rodríguez, Silvia Pérez-Yanes, Iria Lorenzo-Sánchez

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(17), P. 13104 - 13104

Published: Aug. 23, 2023

HIV-1 has evolved a plethora of strategies to overcome the cytoskeletal barrier (i.e., actin and intermediate filaments (AFs IFs) microtubules (MTs)) achieve viral cycle. modifies organization dynamics by acting on associated adaptors molecular motors productively fuse, enter, infect cells then traffic cell surface, where virions assemble are released spread infection. The envelope (Env) initiates cycle binding signaling through its main surface receptors (CD4/CCR5/CXCR4) shape cytoskeleton for fusion pore formation, which permits core entry. Then, capsid is transported nucleus with tracks under control specific adaptors/molecular motors, as well accessory proteins. Furthermore, drives late stages regulating assure Pr55Gag expression transport it assembles buds mature infectious virions. In this review, we therefore analyze how generates cell-permissive state infection factors. Likewise, discuss relevance knowledge understand pathogenesis in patients develop therapeutic battle HIV-1.

Language: Английский

Citations

5

Incidence of pneumonitis following the use of different anaplastic lymphoma kinase tyrosine kinase inhibitor regimens: An updated systematic review and meta‐analysis DOI Creative Commons
Wenting Qie, Qian Zhao, Linlin Yang

et al.

Cancer Medicine, Journal Year: 2023, Volume and Issue: 12(13), P. 13873 - 13884

Published: April 5, 2023

Abstract Objectives Anaplastic lymphoma kinase tyrosine inhibitors (ALK TKIs) have shown remarkable clinical activity in patients with non‐small‐cell lung cancer (NSCLC). However, pneumonitis is a serious side effect of ALK TKIs NSCLC patients. In this meta‐analysis, we aimed to determine the incidence ALK‐TKI‐associated pneumonitis. Materials and Methods We searched electronic databases identify relevant studies published until August 2022. The was calculated using fixed‐effects model when no substantial heterogeneity observed. Otherwise, random‐effects used. Subgroup analyses different treatment groups were performed. Statistical conducted STATA 17.0. Results Twenty‐six trials involving 4752 eligible for analysis. All‐grade 2.92% (95% confidence interval [CI]: 1.79%–4.27%), high‐grade (Grade 3–4) 1.42% CI: 0.84%–2.12%) Grade 5 0.09% 0.00%–0.28%). subgroup analysis showed that brigatinib associated highest both all‐grade (7.09% 3.06%, respectively). TKI after chemotherapy higher than first‐line (7.73% vs. 2.26% 3.64% 1.26%, Cohorts from Japanese had Conclusion Our study provides precise data on receiving TKIs. Overall, tolerable pulmonary toxicity. Early identification are required prevent further deterioration those who received prior chemotherapy, particularly population.

Language: Английский

Citations

4

Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review DOI Open Access
Lidia Gago, Francisco Quiñonero, Gloria Perazzoli

et al.

Published: June 13, 2023

The incidence of gastrointestinal cancers has seen a significant increase in recent years. Current treatments present numerous challenges, including drug resistance, non-specificity, and severe side effects, among others. These issues have necessitated the exploration new therapeutic strategies. One promising avenue is use magnetic nanoparticles, which gained considerable interest due to their ability generate heat tumor regions upon application an external alternating field, process known as hyperthermia. This review conducted systematic search vitro vivo studies published last decade that employ hyperthermia therapy mediated by nanoparticles for treating cancers. After applying various inclusion exclusion criteria, total 40 articles were analyzed. results revealed iron oxide preferred material magnetism generation colorectal cancer most studied cancer. Interestingly, novel therapies employing loaded with chemotherapeutic drugs demonstrated excellent antitumor effect. In conclusion, appear be effective approach treatment cancers, offering advantages over traditional therapies.

Language: Английский

Citations

4

Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy DOI Creative Commons
Ziliang Chen, Kaipeng Jia, Yi Zheng

et al.

Annals of Noninvasive Electrocardiology, Journal Year: 2024, Volume and Issue: 29(1)

Published: Jan. 1, 2024

Abstract Objective Patients treated with preoperative chemotherapy and immunotherapy for bladder cancer may be at increased risk of cardiotoxicity electrophysiological abnormalities. This study aimed to analyze their electrocardiographic (ECG) alterations. Methods who were hospitalized receiving tislelizumab plus nab‐paclitaxel (TnP) enrolled prospectively. ECG, cardiac biomarkers, echocardiography performed baseline the end TnP. Results A total 60 patients (76.7% males), including 30 muscle‐invasive non‐muscle‐invasive cancer, received three or four cycles TnP, respectively. Hypertension was commonest comorbidity (41.7%), 25 (41.7%) prescribed cardiovascular drugs. In comparison characteristics, troponin I (cTnI) N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) within normal ranges after However, echocardiographic parameter left ventricular ejection fraction slightly decreased TnP (62.81 ± 3.81% 61.10 4.37%, p = .011). The incidence abnormal ECG from 65.0% 76.7%, which only a higher prevalence fragmented QRS (fQRS) observed (33.3% 50.0%, .013; mainly in inferior leads). parameters QT dispersion (QTd) prolonged significantly regimen (39.50 11.37 44.20 15.85 ms, .019). Conclusion combined immunotherapy, main abnormality fQRS QTd, relatively biomarkers parameters. Regular screening should carried out carefully detect potential long‐term follow‐up.

Language: Английский

Citations

1